Publication | Closed Access

Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation

TransplantationAngiogenesisNonrelapse MortalityReduced SeverityStem Cell TransplantationHematologyImmunologyGraft SurvivalVascular BiologyAcute Graft-versus-host DiseaseVascular Endothelial Growth FactorMedicineCell TransplantationAtherosclerosisGraft RejectionHealth Sciences